Skip to main content

Want a detailed portfolio tracker?

Comparison NeuroSense Therapeutics (NRSN) with Competitors

NeuroSense Therapeutics (NRSN) industry is Biotechnology.

Free Cash Flow Yield
NRSN-32.81%
Industry-1.75%
Upside-31.06%
P/E
NRSN-2.10
Industry-20.52
Upside+1841.34%
P/B
NRSN2.64
Industry5.15
Upside-48.65%